ABSTRACT

The importance of regulation in the drug development process is well appreciated, but the principles and practices of the major regulatory agencies overseeing therapeutic development are much less understood even by wellinformed academicians. This chapter is intended to provide a better understanding of the regulatory framework and processes that are pertinent to therapeutic development in general and the advancement of therapies for diabetic nephropathy and related conditions in particular.